CLINICAL TRIALS PROFILE FOR ISOSULFAN BLUE

All Clinical Trials for ISOSULFAN BLUE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003186 ↗	Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer	Completed	National Cancer Institute (NCI)	N/A	1997-04-01	RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.
NCT00003186 ↗	Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer	Completed	Roswell Park Cancer Institute	N/A	1997-04-01	RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.
NCT00012168 ↗	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat	Completed	National Cancer Institute (NCI)	N/A	1999-05-01	RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
NCT00012168 ↗	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat	Completed	New York University School of Medicine	N/A	1999-05-01	RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
NCT00012168 ↗	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat	Completed	NYU Langone Health	N/A	1999-05-01	RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.

Clinical Trial Conditions for ISOSULFAN BLUE

Condition Name

Condition Name for ISOSULFAN BLUE
Intervention	Trials
Breast Cancer	5
Colorectal Cancer	2
Stage IV Melanoma	1
Stage IB Melanoma	1

Condition MeSH

Condition MeSH for ISOSULFAN BLUE
Intervention	Trials
Breast Neoplasms	6
Lymphedema	3
Melanoma	3
Colorectal Neoplasms	2

Clinical Trial Locations for ISOSULFAN BLUE

Trials by Country

Trials by Country for ISOSULFAN BLUE
Location	Trials
United States	36

Trials by US State

Trials by US State for ISOSULFAN BLUE
Location	Trials
California	4
Ohio	3
Pennsylvania	3
New York	3
Wisconsin	2

Clinical Trial Progress for ISOSULFAN BLUE

Clinical Trial Phase

Clinical Trial Phase for ISOSULFAN BLUE
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	2
Phase 1/Phase 2	2

Clinical Trial Status

Clinical Trial Status for ISOSULFAN BLUE
Clinical Trial Phase	Trials
Completed	9
Terminated	3
Not yet recruiting	1

Clinical Trial Sponsors for ISOSULFAN BLUE

Sponsor Name

Sponsor Name for ISOSULFAN BLUE
Sponsor	Trials
National Cancer Institute (NCI)	10
Stanford University	2
University of Miami Sylvester Comprehensive Cancer Center	1

Sponsor Type

Sponsor Type for ISOSULFAN BLUE
Sponsor	Trials
Other	17
NIH	11
Industry	1